NCT00757575已完成不适用
Epidemiological Surveillance Network Study To Assess the Disease of Pneumonia in Infants and Children in Japan
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 28,511
- 主要终点
- 1.Describe the distribution of causal pathogen of meningitis and bacteremia 2.Estimate the hospital admission rate of pneumonia patients 3.Estimate the incidence rate of IPD 4.Describe the serotype distribution of S. pneumoniae
研究概览
简要总结
Streptococcus pneumoniae is a major cause of pneumonia, among infants and children in Japan and worldwideThis study plans to investigate the rate of invasive pneumococcal disease "IPD " and the rate of hospitalizations due to pneumonia in Okinawa and the Eastern half of Hokkaido Currently, only a limited information about pneumococcal disease burden is available in Japan.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 28 Days 至 60 Months(Child)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
1.Describe the distribution of causal pathogen of meningitis and bacteremia 2.Estimate the hospital admission rate of pneumonia patients 3.Estimate the incidence rate of IPD 4.Describe the serotype distribution of S. pneumoniae
时间窗: 2 years
次要结局
- 1.CFRof patients admitted with IPD and/or pneumonia. 2.Antibiotic resistance rate of S. pneumoniae 3.Risk factor distribution 4.Average duration of the hospitalization of patients with IPD, meningitis, and/or pneumonia.(2-3 years)
研究者
相似试验
已完成
3 期
Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)Pneumococcal InfectionsStreptococcal InfectionsBacterial InfectionsNCT04841369CanSino Biologics Inc.3,420
已完成
1 期
Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and AbovePneumococcal InfectionsStreptococcal InfectionsBacterial InfectionsNCT04100772CanSino Biologics Inc.237
已完成
不适用
A Study of Streptococcus Pneumonia Colonisation and Invasive Disease in Cambodian ChildrenStreptococcal PneumoniaNCT03331952University of Oxford4,111
招募中
1 期
Phase I Clinical Trial of a Candidate PCV13 in Healthy PeoplePneumococcal InfectionsNCT05602480Wuhan BravoVax Co., Ltd.264
已完成
不适用
Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 MonthsStreptococcus PneumoniaeNCT01425372Prof. Elizabeth Miller93
